» Articles » PMID: 34877500

A Dysbiotic Gut Microbiome Suppresses Antibody Mediated-protection Against

Overview
Journal iScience
Publisher Cell Press
Date 2021 Dec 8
PMID 34877500
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Cholera is a severe diarrheal disease that places a significant burden on global health. Cholera's high morbidity demands effective prophylactic strategies, but oral cholera vaccines exhibit variable efficacy in human populations. One contributor of variance in human populations is the gut microbiome, which in cholera-endemic areas is modulated by malnutrition, cholera, and non-cholera diarrhea. We conducted fecal transplants from healthy human donors and model communities of either human gut microbes that resemble healthy individuals or those of individuals recovering from diarrhea in various mouse models. We show microbiome-specific effects on host antibody responses against , and that dysbiotic human gut microbiomes representative of cholera-endemic areas suppress the immune response against via CD4+ lymphocytes. Our findings suggest that gut microbiome composition at time of infection or vaccination may be pivotal for providing robust mucosal immunity, and suggest a target for improved prophylactic and therapeutic strategies for cholera.

Citing Articles

Vaccination with an HIV T-Cell Immunogen (HTI) Using DNA Primes Followed by a ChAdOx1-MVA Boost Is Immunogenic in Gut Microbiota-Depleted Mice despite Low IL-22 Serum Levels.

Elizalde-Torrent A, Borgognone A, Casadella M, Romero-Martin L, Escriba T, Parera M Vaccines (Basel). 2023; 11(11).

PMID: 38005995 PMC: 10675013. DOI: 10.3390/vaccines11111663.


, classification, pathogenesis, immune response, and trends in vaccine development.

Montero D, Vidal R, Velasco J, George S, Lucero Y, Gomez L Front Med (Lausanne). 2023; 10:1155751.

PMID: 37215733 PMC: 10196187. DOI: 10.3389/fmed.2023.1155751.

References
1.
Cerutti A, Rescigno M . The biology of intestinal immunoglobulin A responses. Immunity. 2008; 28(6):740-50. PMC: 3057455. DOI: 10.1016/j.immuni.2008.05.001. View

2.
Bhuiyan T, Lundin S, Khan A, Lundgren A, Harris J, Calderwood S . Cholera caused by Vibrio cholerae O1 induces T-cell responses in the circulation. Infect Immun. 2009; 77(5):1888-93. PMC: 2681774. DOI: 10.1128/IAI.01101-08. View

3.
Chen W, Cohen M, Kirkpatrick B, Brady R, Galloway D, Gurwith M . Single-dose Live Oral Cholera Vaccine CVD 103-HgR Protects Against Human Experimental Infection With Vibrio cholerae O1 El Tor. Clin Infect Dis. 2016; 62(11):1329-1335. PMC: 4872293. DOI: 10.1093/cid/ciw145. View

4.
Woida P, Satchell K . The MARTX toxin silences the inflammatory response to cytoskeletal damage before inducing actin cytoskeleton collapse. Sci Signal. 2020; 13(614). PMC: 7309453. DOI: 10.1126/scisignal.aaw9447. View

5.
Charles R, Kelly M, Tam J, Akter A, Hossain M, Islam K . Humans Surviving Cholera Develop Antibodies against Vibrio cholerae O-Specific Polysaccharide That Inhibit Pathogen Motility. mBio. 2020; 11(6). PMC: 7683404. DOI: 10.1128/mBio.02847-20. View